J1595 Injection glatiramer acetate
Also known as: glatiramer acetate, Copaxone
Glatiramer acetate injection. An immunosuppressant for relapsing-remitting multiple sclerosis treatment.
In Plain Language
multiple sclerosis medication; disease-modifying injection
Clinical Context
Used for relapsing-remitting multiple sclerosis to reduce frequency and severity of relapses. Subcutaneous administration with immune tolerance mechanism.
RVU Information
CPT J1595 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J1595?
CPT J1595 (Injection glatiramer acetate) is a J Codes (Drugs) code. Glatiramer acetate injection. An immunosuppressant for relapsing-remitting multiple sclerosis treatment.
How is J1595 administered?
CPT J1595 is administered by a healthcare provider, typically via injection or infusion. Used for relapsing-remitting multiple sclerosis to reduce frequency and severity of relapses. Subcutaneous administration with immune tolerance mechanism. It is used by Neurology, Internal Medicine.
When is CPT J1595 used?
Used for relapsing-remitting multiple sclerosis to reduce frequency and severity of relapses. Subcutaneous administration with immune tolerance mechanism.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.